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It is currently estimated that at least 15%-20% of 
all human cancers are associated with viral, bacterial 
and/or parasitic infections as an etiologic agent [1, 2]. 
This  represents  a  significant  global  cancer  burden,  as 
well as a tremendous opportunity for cancer treatment 
and prevention strategies via antibiotic and vaccine 
development. As we continue to realize the complexities 
of infection-associated cancers, we learn that infection by 
a microbial agent is often necessary, but not sufficient for 
cancer development. Progression to cancer often requires 
one or many genetic and/or environmental co-factor(s), 
and only a small fraction of infected individuals will 
eventually develop disease. Recent evidence suggests an 
equally important role for chronic inflammation in cancer 
initiation  and/or  progression.  Chronic  inflammation 
can mediate the cancer process either as a direct result 
of chronic infection, as is the case for the bacterium 
Helicobacter pylori (H. pylori) which is associated with 
gastric  inflammation  and  gastric  cancer,  or  indirectly 
as a co-factor, such as the suspected link between co-
infections with other sexually transmitted infections 
(STIs) and HPV-induced cervical cancer [3]. 
In the case of human prostate cancer, a potential role 
for infectious agents has long been suspected due to the 
frequent observation of unexplained acute and chronic 
inflammation  and  inflammation-associated  lesions  in 
radical  prostatectomy  specimens  [4-6].  Inflammation-
associated microorganisms that can infect the human 
prostate  have  historically  been  identified  via  culture-
dependent methods in the diagnosis of acute bacterial 
prostatitis and primarily include Escherichia coli and 
Enterococcus spp. [7]. With the advent of culture-
independent, molecular-based tools for microbial 
detection, a number of microorganisms have now also 
been  indentified  in  prostate  cancer  tissues,  and  are 
found to be in association with human prostate cancer. 
Interestingly,  many  of  the  organisms  identified  are 
consistent  with  genera  associated  with  inflammation-
associated conditions such as bacterial prostatitis and/
or urinary tract infections [8-11]. In addition to bacteria, 
there have been several reports of viruses identified via 
molecular techniques and found to be in association with 
prostate cancer [12-15]. In the current issue of Oncotarget, 
Barykova  et al. now add Mycoplasma hominis to this 
growing list of microorganisms which are potentially 
associated with prostate cancer. 
Mycoplasma  species are tiny, parasitic bacteria 
which lack a cell wall and are commonly known in the 
biomedical field as a pervasive cell culture contaminant 
which can induce cellular transformation. Due to 
this well-established connection between persistent 
mycoplasma infection and induced transformation of 
cultured cells, mycoplasmas have been postulated to 
play a role in human carcinogenesis [16]. Interestingly, 
although traditionally regarded as human commensals 
as  opposed  to  pro-inflammatory  bacteria,  it  has  been 
proposed that mycoplasmas may be associated with 
chronic prostatitis [17-20], and therefore could also 
potentially serve as a stimulus for chronic inflammation 
in the human prostate. These attributes make Mycoplasma 
spp. of particular interest in regards to a potential role in 
prostate carcinogenesis.
One of the major drawbacks of molecular-based 
techniques for microbial detection is the persistent threat 
of artifact and/or false-positive results due to highly 
sensitive methods for detection as well as the constant 
threat of potential contamination. A very recent and 
relevant example of this concern involves the controversy 
surrounding the discovery of a novel murine retrovirus, Oncotarget 2011; 2:  281 - 283 282 www.impactjournals.com/oncotarget
termed XMRV, in prostate cancer samples from patients 
with homozygous germline RNase L mutations [13]. 
Subsequent to the publication of these findings in 2006, 
multiple laboratories world-wide have attempted to 
detect XMRV in prostate cancer samples, without success 
(reviewed in [21]). Very current evidence suggests 
that the existence of XMRV may in fact be traced back 
to recombination between two separate and defective 
endogenous murine retroviral proviruses that infected the 
CWR22 human prostate cancer cells at some point during 
the process of serial passage of the cells by xenograft in 
immune compromised animals (for review, see [22]). It 
is now postulated that all subsequent detection of XMRV 
in human samples may be linked to either low-level 
contamination by the CWR22Rv1 prostate cancer cell 
line, or to contamination of samples and reagents with 
murine DNA, which has also now been shown to lead to 
false-positive detection of XMRV [23, 24]. 
In the case of the study by Barykova  et al., 
Mycoplasma hominis DNA was detected in transrectal 
prostate  biopsy  samples  by  organism-specific  PCR  at 
either 45 or 50 cycles of amplification. Although most 
commonly known as a commensal organism in the human 
genitourinary tract, Mycoplasma hominis is also present 
in the human rectum [25]. Of interest in this regard, 
Barykova et al. did not detect Mycoplasma hominis in any 
of a series of autopsy samples that were purportedly not 
obtained by transrectal biopsy and represented “lesion-
free” controls. Other studies which utilize universal 
primer sets designed against bacterial 16S ribosomal 
DNA (rDNA) for the detection of bacteria in human 
prostate cancer tissues collected by transperineal biopsy 
or from post-prostatectomy tissues have not detected the 
presence of Mycoplasma spp. [8, 9]. These findings could 
be explained in part however by the use of one “universal” 
primer set designed to detect multiple species of bacteria. 
Broad-range PCR of this manner can suffer from bias 
because ribosomal DNA sequences of sufficient length 
are not perfectly conserved across all species of bacteria. 
We have undertaken additional studies however using 
both a novel mass spectrometry-based platform to provide 
unbiased amplification of bacterial genes [26] as well as 
organism-specific PCR using a commercially available kit 
for Mycoplasma detection on a cohort of prostate tissues 
that were collected post-prostatectomy, and we have 
not detected Mycoplasma spp. in these samples (K.S. 
Sfanos, unpublished data). These findings may warrant 
confirmation of the findings of Barykova et al. in samples 
that were not collected via biopsy through the rectum.
One thing is certain, the work of Barykova et al. 
highlights the important efforts underway to identify 
potential infectious agents that may be linked to the 
chronic  inflammation  so  commonly  observed  in  the 
prostate of cancer patients and that may potentially be 
associated with prostate cancer. Future endeavors in 
establishing a potential causal role for microorganism(s) 
in  prostate carcinogenesis should potentially include 
efforts to localize the organism(s) of interest in prostate 
cancer tissues to determine if the presence of the organism 
correlates to histo-pathological features such as patterns 
of inflammation, or prostatic lesions (atrophy, prostatic 
intraepithelial neoplasia (PIN), cancer). For a relevant 
example, it was not just the identification of Helicobacter 
pylori  in the stomach of cancer patients, but also the 
association of H. pylori  with  gastric  inflammation  and 
gastric atrophy that helped to form the body of evidence 
that eventually proved that H. pylori plays an etiologic 
role in gastric carcinogenesis. 
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